LHC Group, Inc. (NASDAQ:LHCG) Shares Sold by Sumitomo Mitsui Trust Holdings Inc.

Sumitomo Mitsui Trust Holdings Inc. cut its stake in LHC Group, Inc. (NASDAQ:LHCG) by 23.0% during the 2nd quarter, HoldingsChannel reports. The fund owned 284,085 shares of the health services provider’s stock after selling 85,087 shares during the period. Sumitomo Mitsui Trust Holdings Inc.’s holdings in LHC Group were worth $49,522,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. NEXT Financial Group Inc raised its holdings in LHC Group by 1.9% in the second quarter. NEXT Financial Group Inc now owns 3,566 shares of the health services provider’s stock valued at $622,000 after acquiring an additional 65 shares in the last quarter. Moors & Cabot Inc. raised its holdings in shares of LHC Group by 5.9% during the first quarter. Moors & Cabot Inc. now owns 1,800 shares of the health services provider’s stock worth $252,000 after purchasing an additional 100 shares during the period. Zebra Capital Management LLC raised its holdings in shares of LHC Group by 1.9% during the first quarter. Zebra Capital Management LLC now owns 6,249 shares of the health services provider’s stock worth $876,000 after purchasing an additional 115 shares during the period. Sawgrass Asset Management LLC raised its holdings in shares of LHC Group by 7.0% during the first quarter. Sawgrass Asset Management LLC now owns 2,446 shares of the health services provider’s stock worth $343,000 after purchasing an additional 161 shares during the period. Finally, UBS Group AG raised its holdings in shares of LHC Group by 2.5% during the first quarter. UBS Group AG now owns 15,375 shares of the health services provider’s stock worth $2,156,000 after purchasing an additional 379 shares during the period. 94.55% of the stock is currently owned by hedge funds and other institutional investors.

A number of analysts have weighed in on the stock. SunTrust Banks increased their target price on shares of LHC Group from $200.00 to $220.00 and gave the stock a “buy” rating in a report on Thursday, July 9th. Deutsche Bank increased their target price on shares of LHC Group from $160.00 to $165.00 and gave the stock a “buy” rating in a report on Wednesday, June 3rd. Benchmark increased their target price on shares of LHC Group from $160.00 to $190.00 and gave the stock a “buy” rating in a report on Wednesday, July 1st. BidaskClub raised shares of LHC Group from a “buy” rating to a “strong-buy” rating in a report on Wednesday, June 24th. Finally, UBS Group dropped their target price on shares of LHC Group from $179.00 to $170.00 and set a “buy” rating on the stock in a report on Thursday, May 14th. Three analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. LHC Group currently has a consensus rating of “Buy” and a consensus target price of $163.60.

LHCG stock opened at $195.11 on Friday. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.24. LHC Group, Inc. has a fifty-two week low of $100.00 and a fifty-two week high of $199.72. The firm’s 50-day simple moving average is $176.08 and its 200 day simple moving average is $149.60. The stock has a market cap of $6.23 billion, a PE ratio of 61.74, a price-to-earnings-growth ratio of 3.63 and a beta of 0.49.

LHC Group (NASDAQ:LHCG) last announced its earnings results on Thursday, May 7th. The health services provider reported $0.75 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.69 by $0.06. The firm had revenue of $512.90 million during the quarter, compared to analyst estimates of $504.41 million. LHC Group had a net margin of 4.73% and a return on equity of 8.89%. LHC Group’s revenue was up 2.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.98 EPS. Equities analysts forecast that LHC Group, Inc. will post 4.26 EPS for the current fiscal year.

About LHC Group

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.

Read More: Rule of 72

Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group, Inc. (NASDAQ:LHCG).

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.